Evidence map›Paper›PMID 42016602›Full record

ArticleMass spectrometry (Tokyo, Japan)2026

Comprehensive Lipidomic Analysis of Recombinant Protein-Producing CHO Cell Cultures: Insights for Media and Process Development.

Shuwen Chen, Esther Kai Lay Peh, Farouq Bin Mahfut, Yuan Sheng Yang, Yin Ying Ho, Ying Swan Ho

Abstract read
In one paragraph

Article in Mass spectrometry (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shuwen ChenBioprocessing Technology Institute, Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #06-01, Centros, 138668, Singapore.
Esther Kai Lay PehBioprocessing Technology Institute, Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #06-01, Centros, 138668, Singapore.
Farouq Bin MahfutBioprocessing Technology Institute, Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #06-01, Centros, 138668, Singapore.
Yuan Sheng YangBioprocessing Technology Institute, Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #06-01, Centros, 138668, Singapore.
Yin Ying HoBioprocessing Technology Institute, Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #06-01, Centros, 138668, Singapore.
Ying Swan HoBioprocessing Technology Institute, Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #06-01, Centros, 138668, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chinese hamster ovary (CHO) cell expression systems are widely utilized for biologics manufacturing due to their efficient recombinant protein expression and human-like post-translational modifications. With an increasing demand for bio-therapeutic proteins, the development of high-yielding CHO cell lines and refining bioprocess parameters are key to achieving reliable, efficient, and cost-effective therapeutic protein production. Many lipidomic studies on CHO cells have highlighted the crucial roles of lipids in supporting cell growth and specific productivity, offering valuable insights for optimizing culture media and metabolic pathways. Among these lipid classes, sterols such as cholesterol and its downstream intermediates have been investigated in CHO cells, though their functions remain less thoroughly explored compared to overall lipid metabolism. In this study, comprehensive lipidomic profiling, including cholesterol and esterified cholesterol, was performed on two distinct basal media and feed conditions, which identified lipid composition changes that offer mechanistic insights into how culture conditions potentially influence membrane dynamics. These findings provide a foundation for future development of culture media and bioprocess control strategies that can ultimately improve yield and process consistency.

Indexed as

bioprocess developmentChinese hamster ovary (CHO)lipidomicsliquid chromatography-mass spectrometry (LC-MS)recombinant protein production

Identifiers

PMID42016602
PMCPMC13093251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.